Get startedLog in
    Picture of IRulya Therapeutics logo

    IRLA — IRulya Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Quince Therapeutics Presents Preclinical Data At MHSRS 2022

    Picture of IRulya Therapeutics logoIRulya Therapeutics
    16/09/2022 13:16
    Sept 16 (Reuters) - Quince Therapeutics Inc  QNCX.O :
    * QUINCE THERAPEUTICS PRESENTS PRECLINICAL DATA AT MHSRS
2022
DEMONSTRATING PRECLINICAL EFFICACY OF BONE-TARGETING PLATFORM
FOR TRAUMATIC BONE INJURY

Source text for Eikon:  ID:nBw7s6TXGa 
Further company coverage:  QNCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on IRulya Therapeutics

    See all news